Evidence map›Paper›PMID 34224321›Full record

ArticlePrion2021

Upregulation of brain hepcidin in prion diseases.

Suman Chaudhary, Ajay Ashok, Aaron S Wise, Neil A Rana, Dallas McDonald, Alexander E Kritikos, Qingzhong Kong, Neena Singh

Open access · goldAbstract read
In one paragraph

Article in Prion, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. mBio · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Suman ChaudharyDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Ajay AshokDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Aaron S WiseDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Neil A RanaDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Dallas McDonaldDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Alexander E KritikosDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Qingzhong KongDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Neena SinghDepartment of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Case Western Reserve University · US

Funding

The iron modulatory function of prion protein and prion disordersR01NS092145 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI SINGH, NEENA · 2015 to 2019
$2.4M
Local hepcidin in the anterior segment: Physiological and pathological implicationsR21EY032694 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI SINGH, NEENA · 2022 to 2023
$443k
Modulation of brain iron by local hepcidin in prion disordersR21NS125228 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI SINGH, NEENA · 2021 to 2021
$443k
NEI NIH HHS R21 EY032694NINDS NIH HHS R01 NS092145NINDS NIH HHS R21 NS125228
6 · The paper itself

Abstract

Accumulation of redox-active iron in human sporadic Creutzfeldt-Jakob disease (sCJD) brain tissue and scrapie-infected mouse brains has been demonstrated previously. Here, we explored whether upregulation of local hepcidin secreted within the brain is the underlying cause of iron accumulation and associated toxicity. Using scrapie-infected mouse brains, we demonstrate transcriptional upregulation of hepcidin relative to controls. As a result, ferroportin (Fpn), the downstream effector of hepcidin and the only known iron export protein was downregulated, and ferritin, an iron storage protein was upregulated, suggesting increased intracellular iron. A similar transcriptional and translational upregulation of hepcidin, and decreased expression of Fpn and an increase in ferritin expression was observed in sCJD brain tissue. Further evaluation in human neuroblastoma cells (M17) exposed to synthetic mini-hepcidin showed downregulation of Fpn, upregulation of ferritin, and an increase in reactive oxygen species (ROS), resulting in cytotoxicity in a dose-dependent manner. Similar effects were noted in primary neurons isolated from mouse brain. As in M17 cells, primary neurons accumulated ferritin and ROS, and showed toxicity at five times lower concentration of mini-hepcidin. These observations suggest that upregulation of brain hepcidin plays a significant role in iron accumulation and associated neurotoxicity in human and animal prion disorders.

Indexed as

HepcidinsPrion DiseasesAnimalsBrainFerritinsMiceUp-RegulationFerritinsHepcidinsbrain ironferritinferroportinHepcidiniron

Identifiers

PMID34224321
PMCPMC8259718
OpenAlexW3180111138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.